SEC Tracker
Get the app

Outset Medical OM

Outset Medical Q1 FY25: revenue $29.8M, up 6%; diluted EPS −$3.66

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract

Key figures from this report

These are the numbers Outset Medical reported for Q1 FY25, the quarter ended Mar 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$29.8M+6% from $28.2M in Q1 FY2410-Q income statement, on EDGAR
  2. Net income−$25.8MAgainst −$39.9M in Q1 FY2410-Q income statement, on EDGAR
  3. Diluted EPS−$3.66Against −$0.78 in Q1 FY2410-Q income statement, on EDGAR
  4. Cash and cash equivalents$75.9M+136% from $32.2M in Q1 FY24Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations−$25.7MAgainst −$45.9M in Q1 FY2410-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Outset Medical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. ClearPoint Neuro CLPT public float $328M, Jun 30, 2025
  2. EBR Systems EBRCZ public float $351M, Jun 30, 2025
  3. Orthopediatrics KIDS public float $363M, Jun 30, 2025
  4. NeuroPace NPCE public float $306M, Jun 30, 2025
  5. Butterfly Network BFLY public float $384M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.